Allurion Technologies (ALUR) Capital Expenditures (2022 - 2024)
Allurion Technologies (ALUR) posted Capital Expenditures of $580000.0 for Q3 2024, up 894.52% on a QoQ basis from -$73000.0 in Q2 2024, and up 452.38% year-over-year from $105000.0 in Q4 2023.
Allurion Technologies (ALUR) Capital Expenditures (2022 - 2024) Analysis & Trends
Allurion Technologies' Capital Expenditures history runs 3 years deep, the most recent figure standing at $580000.0 for Q3 2024.
- Quarterly Capital Expenditures rose 452.38% year-over-year to $580000.0 in Q3 2024, while the trailing twelve-month figure through Dec 2024 was $611000.0 (down 61.96% YoY) and the FY2024 annual result came in at $611000.0, down 61.96% from the prior year.
- Capital Expenditures was $580000.0 for Q3 2024 at Allurion Technologies, up from -$73000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.3 million in Q4 2023 and bottomed at -$157000.0 in Q3 2022.
- A 3-year average of $279888.9 and a median of $105000.0 in 2023 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 452.38% in 2024, while the deepest fall reached 62.45% in 2024.
- Allurion Technologies' Capital Expenditures stood at $459000.0 in 2022, then jumped by 191.07% to $1.3 million in 2023, then slumped by 56.59% to $580000.0 in 2024.
- Business Quant data shows ALUR's Capital Expenditures at $580000.0 in Q3 2024, -$73000.0 in Q2 2024, and $104000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 580,000.00 |
| Sep 30, 2024 | 580,000.00 |
| Jun 30, 2024 | -73,000.00 |
| Jun 30, 2024 | -73,000.00 |
| Mar 31, 2024 | 104,000.00 |
| Mar 31, 2024 | 104,000.00 |
| Dec 31, 2023 | 1.34 Mn |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | 105,000.00 |
| Sep 30, 2023 | 105,000.00 |
| Jun 30, 2023 | -112,000.00 |
| Jun 30, 2023 | -112,000.00 |
| Mar 31, 2023 | 277,000.00 |
| Mar 31, 2023 | 277,000.00 |
| Dec 31, 2022 | 459,000.00 |
| Dec 31, 2022 | 459,000.00 |
| Sep 30, 2022 | -157,000.00 |
| Sep 30, 2022 | -157,000.00 |